Literature DB >> 1697876

IFN-gamma regulates the expression of the adhesion molecule ELAM-1 and IL-6 production by human endothelial cells in vitro.

J F Leeuwenberg1, E J von Asmuth, T M Jeunhomme, W A Buurman.   

Abstract

In this study two new in vitro effects of IFN-gamma on human umbilical vein endothelial (HUVE) cells were described. First, it was shown that the expression of the adhesion molecule ELAM-1 on activated HUVE cells can be modulated by IFN-gamma. ELAM-1 is normally not expressed by HUVE cells, but its expression can rapidly be induced by TNF, IL-1, or LPS. Maximal expression is reached after 4 to 6 h of activation, and after 24 h the expression disappeared. Whereas IFN-gamma per se did not induce expression of ELAM-1, it enhanced and prolonged the expression of ELAM-1. This enhancement occurred when IFN-gamma was added before activation as well as when added simultaneously with activation. When IFN-gamma was added 6 or 9 h after the activation, the normally ongoing reduction of expression was not only retarded, but the expression increased for at least 3 h. Moreover, IFN-gamma abrogated the refractory period for restimulation. Neither IFN-beta nor IL-6 had any effect on the expression of ELAM-1. The second effect of IFN-gamma on HUVE cells is the capacity to enhance the IL-6 production by these cells. Prestimulation as well as coincubation of IFN-gamma with TNF, IL-1, or LPS resulted in a strongly augmented production of IL-6. The effects of IFN-gamma may in vivo play a role in the regulation of an inflammatory reaction, because ELAM-1 is an adhesion molecule for neutrophils, and IL-6 has an enhancing effect on the cytotoxicity of neutrophils.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697876

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

Review 1.  Interferons 1992. How much of the promise has been realised?

Authors:  M A Volz; C H Kirkpatrick
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

2.  Cytokine release and dynamics of leukocyte populations after CD3/TCR monoclonal antibody treatment.

Authors:  G J Zlabinger; K M Stuhlmeier; R Eher; S Schmaldienst; R Klauser; A Vychytil; B Watschinger; O Traindl; J Kovarik; E Pohanka
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

Review 3.  Cytokines as biological response modifiers.

Authors:  R C Rees
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

Review 4.  Will complex carbohydrate ligands of vascular selectins be the next generation of non-steroidal anti-inflammatory drugs?

Authors:  J L Winkelhake
Journal:  Glycoconj J       Date:  1991-10       Impact factor: 2.916

Review 5.  Selectins.

Authors:  M P Bevilacqua; R M Nelson
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

6.  Effects of serine protease inhibitors on accumulation of polymorphonuclear leukocytes in the lung induced by acute pancreatitis in rats.

Authors:  Y Okumura; H Inoue; Y Fujiyama; T Bamba
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

7.  Allergen-stimulated T lymphocytes from allergic patients induce vascular cell adhesion molecule-1 (VCAM-1) expression and IL-6 production by endothelial cells.

Authors:  Y Delneste; P Jeannin; P Gosset; P Lassalle; E Cardot; I Tillie-Leblond; M Joseph; J Pestel; A B Tonnel
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

8.  Regulation of endothelial adhesion molecules by ligands binding to the scavenger receptor.

Authors:  T Palkama; M L Majuri; P Mattila; M Hurme; R Renkonen
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

9.  Endotoxin activation of endothelium for polymorphonuclear leucocyte transendothelial migration and modulation by interferon-gamma.

Authors:  A C Issekutz; N Lopes
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

10.  Effects of protein tyrosine kinase inhibitors on cytokine-induced adhesion molecule expression by human umbilical vein endothelial cells.

Authors:  M J May; C P Wheeler-Jones; J D Pearson
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.